前列腺增生症是男性老年人常见的一种慢性病,临床主要以排尿不畅为主,严重者可发生急性尿潴留,久之会影响肾功能,给男性老年人的健康带来了极大影响。既往阿科对本病的治疗只限于应用雌激素等,疗效有限,且副作用大。近年来,随着对膀胱颈、前列腺包膜及其腺体、尿道等处α-肾上腺素能受体(下称α-受体)的认识,α-受体阻滞剂治疗前列腺增生症引起了广泛兴趣。我科自1983年以来采用α-受体阻滞剂酚苄明(即苯苄胺)治疗老年人前列腺增生症60例,收到了满意的效果,现报告如下: (一)一般资料 60例年龄为60～84岁,经肛 Benign prostatic hyperplasia is a common chronic disease in male and the elderly. The main clinical problems are mainly poor urination. In severe cases, acute urinary retention may occur and renal function will be affected for a long time, which greatly affects the health of the male elderly. Previous Arco treatment of the disease is limited to the application of estrogen, etc., limited efficacy, and side effects. In recent years, with the bladder neck, the prostate capsule and its glands, urethra and other α-adrenergic receptor (hereinafter referred to as α-receptor) awareness, α-blockers caused by benign prostatic hyperplasia A wide range of interests. Our department since 1983, the use of a-receptor blocker phenoxybenzamine (ie benzenesulfonamide) in the treatment of 60 cases of benign prostatic hyperplasia in the elderly, received satisfactory results, are as follows: (A) General Information 60 cases of age For 60 to 84 years old, by the anus